Class summary at a glance.

Every drug in the Osmotic Laxative class tracked across NADAC, Part D Formulary, Part D Spending, FDA Orange Book, and shortage data. Ranked below by CY24 Part D spend. Click any molecule for the full drug profile.

Molecules in class: 13tracked in Part D
CY24 Part D spend: $116.6Mcombined across class
Total Rx claims: 3.0M1.2M unique beneficiaries
Generic mfrs (active): 16across all molecules

Every drug in this class, ranked by Part D spend.

CY2024 dataCMS Part D Spending Dashboard

Lactulose

Brand: Constulose · 3.0M Part D claims (CY24) · 1.2M beneficiaries · First FDA approval: 1966-07-30

12 generic mfrs 28 plans require PA

Low NADAC$0.013

→

Avg plan cost$2.74

Part D spend $116.6M 214× spread, current vs floor

Class share

100%

of class CY24 spend

View profile →

Lactulose Solution Usp,

Brand: Lactulose Solution · — Part D claims (CY24) · First FDA approval: 2021-04-16

Brand-only (no generics)

Low NADAC$0.013

→

Avg plan cost$0.013

Part D spend — 1× spread, current vs floor

Class share

of class CY24 spend

View profile →

Polyethylene Glycol 3350 and Electrolytes - Unflavored

— Part D claims (CY24) · First FDA approval: 2019-01-10

Brand-only (no generics)

Low NADAC—

→

Avg plan cost—

Part D spend —

Class share

of class CY24 spend

View profile →

Polyethylene Glycol 3350 and Electrolytes With Lemon Flavor

— Part D claims (CY24) · First FDA approval: 2019-01-10

Brand-only (no generics)

Low NADAC$0.005

→

Avg plan cost$0.005

Part D spend — 1× spread, current vs floor

Class share

of class CY24 spend

View profile →

Polyethylene Glycol 3350 and Electrolytes With Orange Flavor

Brand: Polyethylene Glycol 3350 and electrolyteswith Orange Flavor · — Part D claims (CY24) · First FDA approval: 2019-01-10

Brand-only (no generics)

Low NADAC—

→

Avg plan cost—

Part D spend —

Class share

of class CY24 spend

View profile →

Polyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate and Potassium Chloride - Unflavored

— Part D claims (CY24) · First FDA approval: 2015-04-14

Brand-only (no generics)

Low NADAC—

→

Avg plan cost—

Part D spend —

Class share

of class CY24 spend

View profile →

Polyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate and Potassium Chloride With Lemon Flavor

— Part D claims (CY24) · First FDA approval: 2015-04-14

Brand-only (no generics) 0 plans require PA

Low NADAC$0.006

→

Avg plan cost$0.006

Part D spend — 1× spread, current vs floor

Class share

of class CY24 spend

View profile →

Polyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate and Potassium Chloride With Orange Flavor

— Part D claims (CY24) · First FDA approval: 2015-04-14

Brand-only (no generics)

Low NADAC—

→

Avg plan cost—

Part D spend —

Class share

of class CY24 spend

View profile →

Polyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate, Potassium

Brand: PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride · — Part D claims (CY24) · First FDA approval: 2013-02-08

2 generic mfrs

Low NADAC$0.006

→

Avg plan cost$0.006

Part D spend — 1× spread, current vs floor

Class share

of class CY24 spend

View profile →

Polyethylene Glycol 3350, Sodium Sulfate Anhydrous, Sodium Bicarbonate, Sodium Chloride, Potassium

Brand: GoLYTELY · — Part D claims (CY24) · First FDA approval: 1984-07-13

2 generic mfrs 0 plans require PA

Low NADAC$0.005

→

Avg plan cost$0.005

Part D spend — 1× spread, current vs floor

Class share

of class CY24 spend

View profile →

Polyethylene Glycol-3350 and Electrolytes

Brand: GAVILYTE G · — Part D claims (CY24) · First FDA approval: 2009-06-01

Brand-only (no generics) 0 plans require PA

Low NADAC$0.005

→

Avg plan cost$0.005

Part D spend — 1× spread, current vs floor

Class share

of class CY24 spend

View profile →

Polyethylene Glycol-3350 and Electrolytes With Flavor Pack

Brand: GaviLyte - C · — Part D claims (CY24) · First FDA approval: 2009-01-06

Brand-only (no generics) 0 plans require PA

Low NADAC$0.004

→

Avg plan cost$0.004

Part D spend — 1× spread, current vs floor

Class share

of class CY24 spend

View profile →

Polyethylene Glycol-3350, Sodium Chloride, Potassium and Sodium Bicarbonate

Brand: GAVILYTE-N · — Part D claims (CY24) · First FDA approval: 2009-05-28

Brand-only (no generics) 0 plans require PA

Low NADAC$0.006

→

Avg plan cost$0.006

Part D spend — 1× spread, current vs floor

Class share

of class CY24 spend

View profile →

Class summary at a glance.

Every drug in this class, ranked by Part D spend.

Related questions.